InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-18.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by MacKay-Dunn R. Hector, Director. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 7 reports have been recorded. Split: 3 buys · 2 sells. Total volume traded: €140k. History available since 11 May 2021. The latest transaction was disclosed on 21 May 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations7 total
5,630 shares@ US$5.7421.3% of flowCommon StockSEC:0001600620-24-000070:0
8,733 sharesCommon StockSEC:0001600620-23-000018:0
9,310 shares0Common StockSEC:0001600620-23-000018:1
4,818 shares@ US$11.2636.0% of flowCommon StockSEC:0001600620-23-000018:2
5,000 shares@ US$10.9970.0024% mcap84.6% of flowCommon StockSEC:0001628280-22-005882:0
Canonical exit: 7 Jun 2022 (T+90)
500 shares@ US$11.170.0002% mcap7.7% of flowCommon StockSEC:0001628280-21-010163:0
Canonical exit: 9 Aug 2021 (T+90)
500 shares@ US$11.177.7% of flowCommon StockSEC:0001628280-21-010163
Canonical exit: 9 Aug 2021 (T+90)
7 of 7 declarations
About MacKay-Dunn R. Hector
Hector R. MacKay-Dunn is a Board Member at Aurinia Pharmaceuticals Inc. He plays an essential role in the governance of the company, overseeing operations and contributing to growth strategy.
